New Mexico Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Mexico Health Reporter.

Press releases published on June 23, 2026

Jun. 23, 2026

The XLH Network and Kyowa Kirin Launch the XLH Community Guidebook to Help People Navigate Lifelong Journey with XLH

Indeterminate GlobeNewswire

Jun. 23, 2026

Alpha Tau Successfully Treats First Recurrent Glioblastoma Patient Outside of the United States with Alpha DaRT® at Hadassah University Medical Center in Israel

Indeterminate GlobeNewswire

Jun. 23, 2026

Quoin Pharmaceuticals Receives FDA Conditional Approval of QYLEKI™ as the Proposed Brand Name for QRX003 for Netherton Syndrome

Indeterminate GlobeNewswire

Jun. 23, 2026

Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach

Indeterminate GlobeNewswire

Jun. 23, 2026

Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System

Indeterminate GlobeNewswire

Jun. 23, 2026

Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia

Indeterminate GlobeNewswire

Jun. 23, 2026

Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas

Indeterminate GlobeNewswire

Jun. 23, 2026

Integra LifeSciences Announces Key Executive Appointments

Indeterminate GlobeNewswire

Jun. 23, 2026

Kalaris Announces Upcoming Presentation of TH103 Phase 1a Clinical Data at American Society of Retina Specialists; Ph 1b/2 Clinical Trial Actively Enrolling

Indeterminate GlobeNewswire

Jun. 23, 2026

Ichnos Glenmark Innovation (IGI) Announces Appointment of Mariana Cota Stirner, M.D., Ph.D., as Chief Medical Officer

Indeterminate GlobeNewswire

Jun. 23, 2026

Corxel Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Trial of CX11 in Obese and Overweight U.S. Adults

Indeterminate GlobeNewswire

Jun. 23, 2026

INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB

Indeterminate GlobeNewswire

Jun. 23, 2026

Persephone Biosciences’ Science-Backed Infant and Toddler Synbiotics Now Available on Amazon

Indeterminate GlobeNewswire

Jun. 23, 2026

Phathom Pharmaceuticals Completes Patient Enrollment Ahead of Schedule in Phase 2 pHalcon-EoE-201 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE)

Indeterminate GlobeNewswire

Jun. 23, 2026

Zevra Therapeutics Announces Publication of Positive MIPLYFFA® Data from Pediatric Substudy in Infants with Niemann-Pick Disease Type C (NPC)

Indeterminate GlobeNewswire

Jun. 23, 2026

Oryn Therapeutics Advances Next Phase of Orynotide™ Macrocyclic Peptide Platform Development with Expanded Leadership Team and Board Anchored by Accomplished Life Sciences Industry Veterans, Company Builders and Drug Developers

Indeterminate GlobeNewswire

Jun. 23, 2026

BienRaíz Launches Vitamin D3 5000 IU Softgels: A High-Potency, Simple Formula for Everyday Wellness

Indeterminate GlobeNewswire

Jun. 23, 2026

Communiqué de presse : Wayrilz de Sanofi a été approuvé au Japon pour traiter la thrombocytopénie immunitaire

Indeterminate GlobeNewswire

Jun. 23, 2026

Communiqué de presse : Cenrifki (tolebrutinib) de Sanofi approuvé dans l’UE comme premier médicament ciblant la progression du handicap dans la sclérose en plaques secondairement progressive sans rechutes

Indeterminate GlobeNewswire

Jun. 23, 2026

Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire